Article
FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma
26 Jun 2024
Abstract excerpt
Cisplatin (CDDP) is a commonly used chemotherapeutic for osteosarcoma (OS) patients, and drug resistance remains as a major hurdle to undermine the treatment outcome. Here, we investigated the potential involvement of FoxG1 and BNIP3 in CDDP resistance of OS cells. FoxG1 and BNIP3 expression levels were detected in the CDDP-sensitive and CDDP-resistant OS tumors and cell lines. Mitophagy was observed through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
